Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Boston Scientific Corporation
With
University of Pittsburgh
COGNATE is an acute, confirmatory prospective, multi-center study designed to gather data on Brady and CRT-P indicated patients, with no restrictions on the type/brand of leads. This study will enroll up to 80 patients in up to 12 centers. Total duration of the study is expected to be 9 months.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Patients who are scheduled to receive either Pacemaker (dual chamber) or CRT-P devices based on physician discretion
Patients who are willing and capable of participating in all testing associated with this Clinical Investigation
Patients who are age 18 or above, or of legal age to give informed consent specific to state and national law
You may not be if
Patient enrolled in any concurrent study, without Boston Scientific CRM written approval, that may confound the results of this study
Patients with a prosthetic mechanical tricuspid heart valve
Women who are pregnant
Clareo Health | Common Sensing and Right Ventricular Automatic Capture (COGNATE)
